XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2020   1,280,207        
Balance at Dec. 31, 2020   $ 1,280 $ 130,722,286   $ (105,909,384) $ 24,814,182
Unrealized loss on marketable securities           0
Net loss   0 0   (20,621,286) (20,621,286)
Stock-based compensation expense   $ 0 642,952   0 642,952
Sale of common stock and warrants, net of issuance costs (in shares)   673,171        
Sale of common stock and warrants, net of issuance costs   $ 673 31,093,629   0 31,094,302
Issuance of common stock upon exercise of warrants (in shares)   84,600        
Issuance of common stock upon exercise of warrants   $ 85 2,201,365   0 2,201,450
Balance (in shares) at Sep. 30, 2021   2,037,978        
Balance at Sep. 30, 2021   $ 2,038 164,660,232   (126,530,670) 38,131,600
Balance (in shares) at Jun. 30, 2021   2,037,978        
Balance at Jun. 30, 2021   $ 2,038 164,495,840   (114,331,276) 50,166,602
Unrealized loss on marketable securities           0
Net loss   0 0   (12,199,394) (12,199,394)
Stock-based compensation expense   $ 0 164,392   0 164,392
Balance (in shares) at Sep. 30, 2021   2,037,978        
Balance at Sep. 30, 2021   $ 2,038 164,660,232   (126,530,670) 38,131,600
Balance (in shares) at Dec. 31, 2021 0 2,038,185        
Balance at Dec. 31, 2021 $ 0 $ 2,038 164,914,540 $ 0 (130,005,111) 34,911,467
Stock-based compensation expense and vesting of restricted stock units (in shares) 0 851        
Stock-based compensation expense and vesting of restricted stock units $ 0 $ 1 738,141 0 0 738,142
Unrealized loss on marketable securities 0 0 0 (86,955) 0 (86,955)
Net loss $ 0 $ 0 0 0 (11,515,464) (11,515,464)
Sale of Series C preferred stock to related parties (in shares) 10,000 0        
Sale of Series C preferred stock to related parties $ 5,000 $ 0 0 0 0 5,000
Conversion of Series C preferred stock to common stock (in shares) (10,000)          
Conversion of Series C preferred stock to common stock $ (5,000)          
Conversion of Series C preferred stock to common stock (in shares)   200        
Balance (in shares) at Sep. 30, 2022 0 2,039,236        
Balance at Sep. 30, 2022 $ 0 $ 2,039 165,657,681 (86,955) (141,520,575) 24,052,190
Balance (in shares) at Jun. 30, 2022 0 2,038,914        
Balance at Jun. 30, 2022 $ 0 $ 2,038 165,475,801 (86,583) (138,722,253) 26,669,003
Stock-based compensation expense and vesting of restricted stock units (in shares) 0 322        
Stock-based compensation expense and vesting of restricted stock units $ 0 $ 1 181,880 0 0 181,881
Unrealized loss on marketable securities 0 0 0 (372) 0 (372)
Net loss $ 0 $ 0 0 0 (2,798,322) (2,798,322)
Balance (in shares) at Sep. 30, 2022 0 2,039,236        
Balance at Sep. 30, 2022 $ 0 $ 2,039 165,657,681 $ (86,955) $ (141,520,575) $ 24,052,190
Conversion of Series C preferred stock to common stock     $ 5,000